Investigation of Brucella canis and Brucella abortus Seropositivity by In-House Rapid Slide Agglutination Test and In-House ELISA in Northern Cyprus

The incidence of Brucella canis (B. canis) in humans is unknown in Northern Cyprus. In this study, we investigated the prevalence of B. canis and Brucella abortus (B. abortus) infection in human sera and evaluated the results obtained by agglutination-based techniques using standardized antigens mad...

Full description

Saved in:
Bibliographic Details
Published inThe Tohoku Journal of Experimental Medicine Vol. 259; no. 4; pp. 2022.J096 - 326
Main Authors Aykaç, Aslı, Şanlıdağ, Tamer, Süer, Kaya, Güler, Emrah, Gürbilek, Sevil Erdenliğ, Güvenir, Meryem, Sayan, Murat
Format Journal Article
LanguageEnglish
Published Japan Tohoku University Medical Press 2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The incidence of Brucella canis (B. canis) in humans is unknown in Northern Cyprus. In this study, we investigated the prevalence of B. canis and Brucella abortus (B. abortus) infection in human sera and evaluated the results obtained by agglutination-based techniques using standardized antigens made from B. canis comparatively. All of the subjects were negative in terms of Rose-Bengal plate test. Undiluted serum samples were initially screened by rapid slide agglutination test (RSAT), and those which were found positive were retested in the dilution of 1/25-1/200. Confirmation of the positive results was performed by using 2-mercaptoethanol standard agglutination test (SAT). The test antigen was prepared from the less mucoid M (-) variant of B. canis, and 1/1,048 titered dog antiserum was used as positive control. In 225 serum samples, 3.6% (8/225) was positive by B. canis M (-) RSAT, 4.4 % (10/225) was positive by B. canis M (-) indirect enzyme-linked immunosorbent assay (iELISA). 5.3% (12/225) was positive by B. abortus S99 RSAT and 9.8% (22/225) was positive by B. abortus S99 iELISA. Nine samples were positive by both B. abortus S99 RSAT and B. abortus S99 iELISA. Seven samples were positive by both B. canis M (-) RSAT and B. canis M (-) iELISA. One patient was positive by all methods. It is important to evaluate patient samples with RSAT and iELISA. Until the notification system gives better results to the Ministry of Health, in order to reach the real data for Northern Cyprus, multicenter prevalence determination studies should be done for future.
AbstractList The incidence of Brucella canis (B. canis) in humans is unknown in Northern Cyprus. In this study, we investigated the prevalence of B. canis and Brucella abortus (B. abortus) infection in human sera and evaluated the results obtained by agglutination-based techniques using standardized antigens made from B. canis comparatively. All of the subjects were negative in terms of Rose-Bengal plate test. Undiluted serum samples were initially screened by rapid slide agglutination test (RSAT), and those which were found positive were retested in the dilution of 1/25-1/200. Confirmation of the positive results was performed by using 2-mercaptoethanol standard agglutination test (SAT). The test antigen was prepared from the less mucoid M (-) variant of B. canis, and 1/1,048 titered dog antiserum was used as positive control. In 225 serum samples, 3.6% (8/225) was positive by B. canis M (-) RSAT, 4.4 % (10/225) was positive by B. canis M (-) indirect enzyme-linked immunosorbent assay (iELISA). 5.3% (12/225) was positive by B. abortus S99 RSAT and 9.8% (22/225) was positive by B. abortus S99 iELISA. Nine samples were positive by both B. abortus S99 RSAT and B. abortus S99 iELISA. Seven samples were positive by both B. canis M (-) RSAT and B. canis M (-) iELISA. One patient was positive by all methods. It is important to evaluate patient samples with RSAT and iELISA. Until the notification system gives better results to the Ministry of Health, in order to reach the real data for Northern Cyprus, multicenter prevalence determination studies should be done for future.
The incidence of Brucella canis (B. canis) in humans is unknown in Northern Cyprus. In this study, we investigated the prevalence of B. canis and Brucella abortus (B. abortus) infection in human sera and evaluated the results obtained by agglutination-based techniques using standardized antigens made from B. canis comparatively. All of the subjects were negative in terms of Rose-Bengal plate test. Undiluted serum samples were initially screened by rapid slide agglutination test (RSAT), and those which were found positive were retested in the dilution of 1/25-1/200. Confirmation of the positive results was performed by using 2-mercaptoethanol standard agglutination test (SAT). The test antigen was prepared from the less mucoid M (-) variant of B. canis, and 1/1,048 titered dog antiserum was used as positive control. In 225 serum samples, 3.6% (8/225) was positive by B. canis M (-) RSAT, 4.4 % (10/225) was positive by B. canis M (-) indirect enzyme-linked immunosorbent assay (iELISA). 5.3% (12/225) was positive by B. abortus S99 RSAT and 9.8% (22/225) was positive by B. abortus S99 iELISA. Nine samples were positive by both B. abortus S99 RSAT and B. abortus S99 iELISA. Seven samples were positive by both B. canis M (-) RSAT and B. canis M (-) iELISA. One patient was positive by all methods. It is important to evaluate patient samples with RSAT and iELISA. Until the notification system gives better results to the Ministry of Health, in order to reach the real data for Northern Cyprus, multicenter prevalence determination studies should be done for future.The incidence of Brucella canis (B. canis) in humans is unknown in Northern Cyprus. In this study, we investigated the prevalence of B. canis and Brucella abortus (B. abortus) infection in human sera and evaluated the results obtained by agglutination-based techniques using standardized antigens made from B. canis comparatively. All of the subjects were negative in terms of Rose-Bengal plate test. Undiluted serum samples were initially screened by rapid slide agglutination test (RSAT), and those which were found positive were retested in the dilution of 1/25-1/200. Confirmation of the positive results was performed by using 2-mercaptoethanol standard agglutination test (SAT). The test antigen was prepared from the less mucoid M (-) variant of B. canis, and 1/1,048 titered dog antiserum was used as positive control. In 225 serum samples, 3.6% (8/225) was positive by B. canis M (-) RSAT, 4.4 % (10/225) was positive by B. canis M (-) indirect enzyme-linked immunosorbent assay (iELISA). 5.3% (12/225) was positive by B. abortus S99 RSAT and 9.8% (22/225) was positive by B. abortus S99 iELISA. Nine samples were positive by both B. abortus S99 RSAT and B. abortus S99 iELISA. Seven samples were positive by both B. canis M (-) RSAT and B. canis M (-) iELISA. One patient was positive by all methods. It is important to evaluate patient samples with RSAT and iELISA. Until the notification system gives better results to the Ministry of Health, in order to reach the real data for Northern Cyprus, multicenter prevalence determination studies should be done for future.
ArticleNumber 2022.J096
Author Şanlıdağ, Tamer
Gürbilek, Sevil Erdenliğ
Güvenir, Meryem
Sayan, Murat
Güler, Emrah
Süer, Kaya
Aykaç, Aslı
Author_xml – sequence: 1
  fullname: Aykaç, Aslı
  organization: Department of Biophysic, Faculty of Medicine, Near East University
– sequence: 1
  fullname: Şanlıdağ, Tamer
  organization: DESAM Research Institute, Near East University
– sequence: 1
  fullname: Süer, Kaya
  organization: Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Near East University
– sequence: 1
  fullname: Güler, Emrah
  organization: Department Molecular Biology and Genetic, Faculty of Arts and Sciences, European University of Lefke
– sequence: 1
  fullname: Gürbilek, Sevil Erdenliğ
  organization: Department of Microbiology, Faculty of Veterinary Medicine, Harran University
– sequence: 1
  fullname: Güvenir, Meryem
  organization: Department of Medical Microbiology, Faculty of Medicine, Cyprus University of Health and Social Sciences
– sequence: 1
  fullname: Sayan, Murat
  organization: Clinical Laboratory, PCR Unit, Faculty of Medicine, Kocaeli University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36384858$$D View this record in MEDLINE/PubMed
BookMark eNp1kc9v2yAcxdHUaU27XXecOO7iDAMGfMyi_kgVrVLTnREGnBI52AMcKf_H_uA5cZNJlSohgdDnPd6XdwUufOstAF9zNM0ZRj_Sxm6nGGE8fUAl-wAmOaFlRgguL8AEIYoywTG_BFcxbhAiFHH2CVwSRgQVhZiAvwu_szG5tUqu9bCt4c_Qa9s0CmrlXYTKm_9XqmpD6iNc2dB2bXTJ7Vzaw2oPFz67b_to4ZPqnIGrxhkLZ-t10yfnR-_n4Z2j3Zm9WS5WM-g8_DXYvtjg4XzfhT5-Bh9r1UT75XW_Br9vb57n99ny8W4xny0zXZQkZZaZHHNUKEprUSKhiNbDKgoujKgYL2mhTKWZYVyxOtcFooyjkoqSGowFI9fg--jbhfZPP8STWxePk3o7BJSYE04ZRWUxoN9e0b7aWiO74LYq7OXpJweAjoAObYzB1lK7dBw8BeUamSN5KEweCpOHwuShsEE2fSM7Ob8rWI6CTUxqbc-4Csnpxo64Mrshp0Snw1l-xvSLCtJ68g-8CbXv
CitedBy_id crossref_primary_10_3390_bios14080388
crossref_primary_10_2478_am_2024_0013
crossref_primary_10_3389_fcimb_2024_1493492
Cites_doi 10.3201/eid0302.970219
10.1016/j.rvsc.2010.07.004
10.1111/zph.12102
10.1016/j.rvsc.2007.02.006
10.1038/s41598-020-62849-4
10.1099/jmm.0.45927-0
10.1017/S0950268809990525
10.1179/joc.2008.20.4.431
10.3201/eid1001.020622
10.1080/15321810701454789
10.7883/yoken.64.516
10.3389/fpubh.2021.669278
ContentType Journal Article
Copyright 2022 Tohoku University Medical Press
Copyright_xml – notice: 2022 Tohoku University Medical Press
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1620/tjem.2022.J096
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1349-3329
EndPage 326
ExternalDocumentID 36384858
10_1620_tjem_2022_J096
article_tjem_advpub_0_advpub_2022_J096_article_char_en
Genre Multicenter Study
Journal Article
GeographicLocations Cyprus
GeographicLocations_xml – name: Cyprus
GroupedDBID ---
-~X
.55
.GJ
123
29Q
2WC
36B
3O-
53G
5RE
7.U
ABCQX
ACGFO
ADBBV
AEGXH
AENEX
AIAGR
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
E3Z
EBD
EMB
EMOBN
F5P
GX1
JSF
JSH
KQ8
L7B
MK0
OK1
OVT
P2P
RJT
RNS
RZJ
SV3
TKC
TR2
W2D
WH7
X7J
X7M
XSB
ZGI
ZXP
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
M~E
NPM
7X8
ID FETCH-LOGICAL-c593t-e6d12705a44f8908a3cc3cc5578d8b67945adbc6d67a6f1c50467094894d22863
ISSN 0040-8727
1349-3329
IngestDate Fri Jul 11 00:21:26 EDT 2025
Thu Jan 02 22:52:07 EST 2025
Thu Apr 24 22:52:58 EDT 2025
Tue Jul 01 01:29:01 EDT 2025
Wed Sep 03 06:30:39 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Northern Cyprus
In-house
Brucella abortus
Brucella canis
brucellosis
ELISA
Language English
License https://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c593t-e6d12705a44f8908a3cc3cc5578d8b67945adbc6d67a6f1c50467094894d22863
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/tjem/advpub/0/advpub_2022.J096/_article/-char/en
PMID 36384858
PQID 2737464095
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2737464095
pubmed_primary_36384858
crossref_citationtrail_10_1620_tjem_2022_J096
crossref_primary_10_1620_tjem_2022_J096
jstage_primary_article_tjem_advpub_0_advpub_2022_J096_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-00-00
PublicationDateYYYYMMDD 2023-01-01
PublicationDate_xml – year: 2023
  text: 2023-00-00
PublicationDecade 2020
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle The Tohoku Journal of Experimental Medicine
PublicationTitleAlternate Tohoku J. Exp. Med.
PublicationYear 2023
Publisher Tohoku University Medical Press
Publisher_xml – name: Tohoku University Medical Press
References 11
22
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
10
21
References_xml – ident: 2
– ident: 5
– ident: 6
  doi: 10.3201/eid0302.970219
– ident: 7
  doi: 10.1016/j.rvsc.2010.07.004
– ident: 13
  doi: 10.1111/zph.12102
– ident: 1
– ident: 12
– ident: 11
– ident: 3
  doi: 10.1016/j.rvsc.2007.02.006
– ident: 4
  doi: 10.1038/s41598-020-62849-4
– ident: 15
  doi: 10.1099/jmm.0.45927-0
– ident: 19
– ident: 14
  doi: 10.1017/S0950268809990525
– ident: 18
  doi: 10.1179/joc.2008.20.4.431
– ident: 20
  doi: 10.3201/eid1001.020622
– ident: 16
  doi: 10.1080/15321810701454789
– ident: 9
– ident: 8
– ident: 17
  doi: 10.7883/yoken.64.516
– ident: 10
  doi: 10.3389/fpubh.2021.669278
– ident: 21
– ident: 22
SSID ssj0034076
Score 2.3278854
Snippet The incidence of Brucella canis (B. canis) in humans is unknown in Northern Cyprus. In this study, we investigated the prevalence of B. canis and Brucella...
SourceID proquest
pubmed
crossref
jstage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2022.J096
SubjectTerms Agglutination Tests - veterinary
Animals
Antibodies, Bacterial
Antigens, Bacterial - analysis
Brucella abortus
Brucella canis
Brucellosis - epidemiology
Brucellosis - veterinary
Cyprus
Dogs
Enzyme-Linked Immunosorbent Assay - methods
Humans
Title Investigation of Brucella canis and Brucella abortus Seropositivity by In-House Rapid Slide Agglutination Test and In-House ELISA in Northern Cyprus
URI https://www.jstage.jst.go.jp/article/tjem/advpub/0/advpub_2022.J096/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/36384858
https://www.proquest.com/docview/2737464095
Volume 259
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX The Tohoku Journal of Experimental Medicine, 2022, pp.2022.J096
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKQIgXxJ1yk5GQeKhS0sRxkseuKusmygPrpL5Fcex02SWpthSp_A5-Hj-G40tMUzppIFVR5dhJmu_rufn4GKEPuUcECVjuhFxOMzI3cqIo8x0SiUHOaZoKVy5Onn6lkxNyNA_mnc6vjaylVc362Y-d60r-B1VoA1zlKtl_QNZeFBrgO-ALR0AYjrfCeKNIhjb7FFIArMzlKnT1Zdsk0a5X11I6VDpVS20bAebnYelMqtW16H1LlwXYnxcFF73hYiEfXQcLezO4j0kdNn3HXw6PhzJaomZ-5H5qo_XyyoQRjLU7q06r89VmdYrWhgLb8_rHctZ-f9SkeaytxjjQJ0AuF-rcVICncGm5uj5P1Xx_qASdNpf3B1uDzYrH8WUTATehDr0OuRHcxAXBrcsI9IWW1T6JHd83ARMjzD1TX7zYDFUo0ewb0ay1vK_X6f-lQKgnMy7rMyGrFHhe_8iNd1Tq3tKgNq9RelRwhUSOT-T4RI6_g-564MRItXEwtwlIPrjStMnplD_NlBSF8Z_a92-ZTPfOwGtYiJsdImUYzR6hh8ajwUNNz8eoI8on6P7UYPsU_WyxFFc5biiJFUsx0OpPk2EpbrMUszVumIcVS7FiKW6xFEuWqsvZvoqluChxw1KsWfoMnXwez0YTx-wF4mRB7NeOoFzmSAQpIXkUu1HqZxl8AlA4PGIUtEqQcpZRTsOU5oMscImsTEiimHDPi6j_HO2VVSleIjwYUDel1OVgvRHG8pgzzlnICHc5cXnYRU7zupPMFMqX-7VcJLvh7aKPtv9Sl4i5sedYo2f7GdGh-6X8OwCZuM0XO852kysxQfB10fsG_AS0gcKnFPBaE3BGQkIJ-E1d9EKzwt7LB1VLoiB6devnfY0eyL-hjji-QXv11Uq8BRu8Zu8UlX8DQgTgKw
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Investigation+of+Brucella+canis+and+Brucella+abortus+Seropositivity+by+In-House+Rapid+Slide+Agglutination+Test+and+In-House+ELISA+in+Northern+Cyprus&rft.jtitle=Tohoku+journal+of+experimental+medicine&rft.au=S%C3%BCer%2C+Kaya&rft.au=G%C3%BCvenir%2C+Meryem&rft.au=Ayka%C3%A7%2C+Asl%C4%B1&rft.au=G%C3%BCler%2C+Emrah&rft.date=2023&rft.issn=0040-8727&rft.eissn=1349-3329&rft.volume=259&rft.issue=4&rft.spage=319&rft.epage=326&rft_id=info:doi/10.1620%2Ftjem.2022.J096&rft.externalDBID=n%2Fa&rft.externalDocID=10_1620_tjem_2022_J096
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0040-8727&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0040-8727&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0040-8727&client=summon